BioLife Solutions Inc (BLFS)
Cash ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 95,386 | 27,896 | 19,442 | 69,860 | 90,403 |
| Short-term investments | US$ in thousands | 9,198 | 16,893 | 44,658 | 40 | 5,872 |
| Total current liabilities | US$ in thousands | 32,734 | 42,178 | 44,582 | 42,700 | 15,573 |
| Cash ratio | 3.19 | 1.06 | 1.44 | 1.64 | 6.18 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($95,386K
+ $9,198K)
÷ $32,734K
= 3.19
The cash ratio of BioLife Solutions Inc, which measures the company's ability to cover its short-term liabilities with its cash and cash equivalents, has shown some fluctuation over the years.
As of December 31, 2020, the cash ratio was 6.18, indicating that the company had a strong ability to cover its short-term obligations with its cash reserves. However, the ratio decreased significantly by December 31, 2023, to 1.06, suggesting a decreased liquidity position compared to the prior years.
By December 31, 2024, the cash ratio improved to 3.19, showing an enhancement in the company's ability to meet its short-term liabilities with its available cash. Overall, fluctuations in the cash ratio of BioLife Solutions Inc over the years may indicate changes in the company's cash management practices and liquidity position. Investors and stakeholders should further investigate the reasons behind these fluctuations to assess the company's financial health accurately.
Peer comparison
Dec 31, 2024